Clik here to view.
世界患者安全峰会虽然额满，但分组讨论会仍有空位，分组讨论会将于世界峰会次日在伦敦皇家学会召开
伦敦 (美国商业资讯) — 患者安全运动基金会主办的世界患者安全科技峰会第6届年会将在伦敦召开，峰会各分组讨论会将讨论疫苗安全的最新进展、减少不必要剖腹产、个人及患者参与。这些分组讨论会将于2018年2月25日在尊贵的皇家学会召开，皇家学会是英国及英联邦的独立科学院，致力于促进科学典范。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ACG Signs MoU with Applied DNA Sciences to Enhance Capsule Authentication and...
STONY BROOK, N.Y. & MUMBAI, India Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), and ACG have signed a memorandum of understanding (MoU) that will allow ACG to...
View ArticleClik here to view.
Maxinovel Pharmaceuticals Announces the Presentation of Its Orally Active...
GUANGZHOU, China Maxinovel Pharmaceuticals today announces that it will present preclinical results of its orally active PD-1/PD-L1 inhibitors as a single agent or combination with Epacadostat,...
View ArticleClik here to view.
Exelixis Announces Collaborator Daiichi Sankyo’s Submission of Regulatory...
SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ: EXEL) today announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has submitted its regulatory application for esaxerenone...
View ArticleClik here to view.
EpimAb Biotherapeutics Appoints Industry Veteran Bin Peng as Chief Medical...
SHANGHAI EpimAb Biotherapeutics, a biologics company based in Shanghai, China, specialized in developing a portfolio of bispecific antibodies, announced today that Bin Peng, MD, PhD, has joined the...
View ArticleClik here to view.
因医疗差错而失去新生儿子的母亲加入世界患者安全科技峰会专家小组
伦敦 (美国商业资讯) — 新晋母亲Deahna Visscher满怀希望。尽管她的儿子Grant出生时有心脏缺损，但在手术后恢复良好。出生仅11天后，医生即判定他可很快出院。但他没能出院。护士在插鼻饲管时操作失误，鼻饲管刺穿了他的气管，导致肺部积液。Deahna回忆道：“护士让我离开病室去呼救，我告诉他们孩子出现青紫，然后20位医护人员试图进行心肺复苏。”Grant于晚间9:10宣告死亡。...
View ArticleClik here to view.
Clik here to view.
Cullgen Announces Series Seed Financing
TOKYO Cullgen Inc. announced a Series Seed Financing of up to $15M by GNI Group Ltd. (GNIG) (TOKYO: 2160) to build a new drug discovery platform based on advanced ubiquitin-mediated protein...
View ArticleClik here to view.
Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Epitinib in...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a Phase Ib/II proof-of-concept study of epitinib in glioblastoma patients with epidermal growth factor receptor...
View ArticleClik here to view.
Synergy Biomedical Announces Regulatory Clearance and Launch of BIOSPHERE...
COLLEGEVILLE, Pa. Synergy Biomedical, LLC, a developer of orthobiologic and biomaterial products, announced that it has received Therapeutic Goods Administration (TGA) clearance in Australia for its...
View ArticleClik here to view.
Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to...
View ArticleClik here to view.
AmpliPhi Biosciences Announces Presentation of Preclinical Data Demonstrating...
SAN DIEGO AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections,...
View ArticleClik here to view.
New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Cairo University in Egypt evaluated the accuracy and trending of...
View ArticleClik here to view.
サンバイオと日立化成：再生医療等製品「SB623」の製造に関する業務提携に合意
東京 （ビジネスワイヤ） – サンバイオグループ（本社：東京都中央区、社長：森 敬太、以下「サンバイオ」）と日立化成株式会社（本社：東京都千代田区、執行役社長：丸山 寿、以下「日立化成」）は、この度サンバイオと、日立化成の子会社で再生医療等製品*1の受託製造事業を行うHitachi Chemical Advanced Therapeutics Solutions,...
View ArticleClik here to view.
SanBio Reaches Agreement on Manufacture of Regenerative Medicine Product...
TOKYO SanBio Group and Hitachi Chemical Co., Ltd. (Hitachi Chemical) jointly announced today that, through an agreement with Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS; formerly...
View ArticleClik here to view.
新研究调查急性出血期间和补液复苏后Masimo SpHb®的性能
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了近期发表的一项研究结果，在该研究中，埃及开罗大学研究人员评估了急性出血期间和补液复苏后 Masimo血红蛋白无创连续测定(SpHb®)相对于血红蛋白创伤性实验室测定(Lab-Hb)的精度和趋势1。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
急性出血中と急速輸液後におけるMasimo SpHb®の性能を検討する新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、エジプトのカイロ大学の研究者らが最近公表した研究の知見について発表しました。この研究は、急性出血中と急速輸液後に、マシモの非侵襲的かつ連続的なヘモグロビン測定値（SpHb®）を検査室での侵襲的ヘモグロビン測定値（Lab-Hb）と比較したものです1。...
View ArticleClik here to view.
ソウル半導体の太陽光LED “SunLike”、中国イーライトのスマートランプに採用
韓国安山市 （ビジネスワイヤ） — 世界的なLED （発光ダイオード）専業メーカーのSeoul Semiconductor Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウル半導体」)は、革新的なIT専門企業シャオミ(Xiaomi)社のエコチェーンカンパニーであり、インテリジェント照明業界のリーダーであるYeelight (www.yeelight.com、代表：Jiang...
View ArticleClik here to view.
Tokai-Denshi Developed A.I.-Equipped Portable Odor Detector/Identifier...
FUJI, Japan Tokai-Denshi Inc. and The Shizuoka Cancer Center Research Institute jointly developed an A.I.-based Portable Odor detector/Identifier which analyzes malodorous components emitted from...
View ArticleClik here to view.
Cellvizio® Obtains Positive Assessment from the Korean National...
PARIS Regulatory News: Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary probe-based confocal laser endomicroscopy (pCLE) platform, today announced...
View Article